Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Retatrutide does act on the GLP-1 receptor, but it is not a GLP-1-only medication like semaglutide
Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma
Other options include Mounjaro and Trulicity
Summary: The retatrutide phase 2 NEJM trial reported mean body weight reductions of up to approximately 24.2% at 48 weeks with the 12 mg dose in adults with obesity without type 2 diabetes
US$ 25.17
US$ 24.18
US$ 27.48
US$ 24.17
US$ 20.11
US$ 20.41
US$ 29.22
US$ 24.50
US$ 20.70
US$ 25.78
